Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, Next
Reported
DateTime		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportFiling
2023-02-13
5:54 pm
Sale		13GIVERIC bio, Inc.
ISEE		Vivo Capital IX LLC0
0%		-5,202,348decrease
(Position Closed)		View
2023-02-13
5:52 pm
Sale		13GTarsus Pharmaceuticals, Inc.
TARS		Vivo Capital IX LLC2,262,200
8.5%		-725,131decrease
(-24.27%)		View
2023-02-13
5:51 pm
Unchanged		13GGenetron Holdings Limited
GTH		Vivo Capital IX LLC28,574,300
6.3%		0
(Unchanged)		View
2023-02-13
5:48 pm
Sale		13GMereo BioPharma Group plc
MREO		Vivo Capital IX LLC3,761,947
3.1%		-5,647,104decrease
(-60.02%)		View
2023-02-13
5:44 pm
Purchase		13GKalVista Pharmaceuticals, Inc.
KALV		Vivo Capital IX LLC772,068
2.3%		772,068increase
(New Position)		View
2022-07-05
5:06 pm
Sale		13GSierra Oncology Inc.
SRRA		Vivo Capital IX LLC0
0%		-2,735,852decrease
(Position Closed)		View
2022-02-11
5:27 pm
Sale		13GLarimar Therapeutics, Inc.
LRMR		Vivo Capital IX LLC326,888
1.8%		-326,891decrease
(-50.00%)		View
2022-02-11
5:26 pm
Purchase		13GMereo BioPharma Group plc
MREO		Vivo Capital IX LLC9,409,051
7.8%		448,755increase
(+5.01%)		View
2022-02-11
5:25 pm
Purchase		13GIVERIC bio, Inc.
ISEE		Vivo Capital IX LLC5,202,348
4.5%		324,300increase
(+6.65%)		View
2022-02-11
5:23 pm
Purchase		13GESSA Pharma Inc.
EPIX		Vivo Capital IX LLC624,902
1.4%		624,902increase
(New Position)		View
2022-02-11
5:22 pm
Purchase		13GSierra Oncology Inc.
SRRA		Vivo Capital IX LLC2,735,852
14.7%		799,999increase
(+41.33%)		View
2022-02-11
5:21 pm
Sale		13GTarsus Pharmaceuticals, Inc.
TARS		Vivo Capital IX LLC2,987,331
14.4%		-257,704decrease
(-7.94%)		View
2021-11-12
4:30 pm
Purchase		13GIO Biotech, Inc.
IOBT		Vivo Capital IX LLC3,015,545
10.5%		3,015,545increase
(New Position)		View
2021-11-05
5:00 pm
Purchase		13GSierra Oncology Inc.
SRRA		Vivo Capital IX LLC1,935,853
14.8%		480,277increase
(+33.00%)		View
2021-07-23
4:30 pm
Purchase		13GSera Prognostics, Inc.
SERA		Vivo Capital IX LLC1,856,011
6.4%		1,856,011increase
(New Position)		View
2021-04-01
4:33 pm
Purchase		13GInstil Bio, Inc.
TIL		Vivo Capital IX LLC12,486,787
9.7%		12,486,787increase
(New Position)		View
2021-02-16
4:30 pm
Sale		13GMereo BioPharma Group plc
MREO		Vivo Capital IX LLC8,960,296
8.168%		-21,635,328decrease
(-70.71%)		View
2021-02-12
4:30 pm
Sale		13GChinook Therapeutics, Inc.
KDNY		Vivo Capital IX LLC987,624
2.3%		-3,197,152decrease
(-76.40%)		View
2021-02-12
4:30 pm
Sale		13GMatinas BioPharma Holdings, Inc.
MTNB		Vivo Capital IX LLC5,274,638
2.6%		-5,002,825decrease
(-48.68%)		View
2021-02-12
4:30 pm
Purchase		13GESSA Pharma Inc.
EPIX		Vivo Capital IX LLC1,562,603
4.7%		152,089increase
(+10.78%)		View
Goto 0, 1, Next